The observation that MTAP is also involved in pediatric gliomas is of foremost importance since in very recent surveys [22, 23] it was revealed that MTAP deleted cancers were rendered therapeutically vulnerable at the methionine salvage pathway. The gene discussed is MTAP; the disease is glioma.